Candida albicans is an opportunistic fungal pathogen responsible for systemic infections that result in considerable morbidity and mortality. The enzyme Exo-1,3 β-glucanase is essential for cell wall metabolism and pathogenicity in C. albicans, rendering
Ririn Puspadewi +2 more
doaj +1 more source
672. Activity of Ibrexafungerp (Formerly SCY-078) Against Candida auris: In vitro, In Vivo, and Clinical Case Studies of Candidemia [PDF]
Stephen Barat +4 more
openalex +1 more source
Ibrexafungerp for the treatment of vulvovaginal candidiasis: A systematic review and meta-analysis of randomized placebo-controlled trials [PDF]
Chia Siang Kow +3 more
openalex +1 more source
871. Oral Ibrexafungerp Outcomes by Fungal Disease in Patients from an Interim Analysis of a Phase 3 Open-label Study (FURI) [PDF]
George R. Thompson +4 more
openalex +1 more source
Terapias alternativas para tratamento da candidíase vulvovaginal: uma revisão integrativa [PDF]
An integrative review that aims to compare some of the different types of treatment for Vaginal Candidiasis and their effectiveness. METHODS: A search was carried out in databases: Bireme, Scielo and PubMeD.
Borba, Karoline Bunn +1 more
core +1 more source
Brilacidin, a host defense peptide mimetic, potentiates ibrexafungerp antifungal activity against the human pathogenic fungus Aspergillus fumigatus [PDF]
Thaila Fernanda dos Reis +4 more
openalex +1 more source
733. Ibrexafungerp Demonstrates Potent and Consistent In Vitro Activity Against >400 Global Candida auris Isolates, Including isolates with Elevated MIC’s to Echinocandins [PDF]
Katyna Borroto–Esoda +2 more
openalex +1 more source
Candida auris: an emerging antimicrobial-resistant organism with the highest level of concern
Mishra Baishnab, Shyam Kumar +3 more
core +1 more source

